|
Nemaura Medical Inc. (NMRD) تقييم DCF
US | Healthcare | Medical - Devices | NASDAQ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Nemaura Medical Inc. (NMRD) Bundle
تُمكّنك حاسبة DCF Nemaura Medical Inc. (NMRD) DCF من تقييم تقييم Nemaura Medical باستخدام البيانات المالية الفعلية ، مع تقديم مرونة كاملة لتعديل جميع المعلمات الأساسية للتوقعات المحسنة.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .0 | .0 | .0 | .5 | .1 | .1 | .0 | .0 | .0 | .0 |
| Revenue Growth, % | 0 | 0 | 0 | 0 | -84.71 | -21.18 | -21.18 | -21.18 | -21.18 | -21.18 |
| EBITDA | -4.4 | -4.7 | -4.5 | -7.3 | -7.3 | .0 | .0 | .0 | .0 | .0 |
| EBITDA, % | 100 | 100 | 100 | -1456.74 | -9458.31 | 20 | 20 | 20 | 20 | 20 |
| Depreciation | .0 | .1 | .1 | .2 | .4 | .1 | .0 | .0 | .0 | .0 |
| Depreciation, % | 100 | 100 | 100 | 45.61 | 576.52 | 89.12 | 89.12 | 89.12 | 89.12 | 89.12 |
| EBIT | -4.5 | -4.8 | -4.6 | -7.6 | -7.7 | .0 | .0 | .0 | .0 | .0 |
| EBIT, % | 100 | 100 | 100 | -1502.35 | -10034.83 | 20 | 20 | 20 | 20 | 20 |
| Total Cash | 3.7 | .1 | 31.9 | 17.7 | 10.1 | .1 | .0 | .0 | .0 | .0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .1 | .1 | .1 | .4 | .1 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 100 | 100 | 100 | 20.1 | 531.71 | 84.02 | 84.02 | 84.02 | 84.02 | 84.02 |
| Inventories | .0 | .3 | .9 | 1.5 | 1.8 | .1 | .0 | .0 | .0 | .0 |
| Inventories, % | 100 | 100 | 100 | 295.25 | 2277.73 | 100 | 100 | 100 | 100 | 100 |
| Accounts Payable | .2 | .3 | .3 | .1 | .3 | .1 | .0 | .0 | .0 | .0 |
| Accounts Payable, % | 100 | 100 | 100 | 27.05 | 423.97 | 85.41 | 85.41 | 85.41 | 85.41 | 85.41 |
| Capital Expenditure | -.1 | -.2 | -.8 | -1.0 | -.5 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | 100 | 100 | 100 | -189.81 | -699.88 | -40 | -40 | -40 | -40 | -40 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -4.5 | -4.2 | -4.4 | -7.4 | -7.7 | .0 | .0 | .0 | .0 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -4.4 | -4.5 | -5.7 | -8.9 | -8.2 | 1.8 | .0 | .0 | .0 | .0 |
| WACC, % | 32.01 | 27.89 | 30.38 | 31.22 | 32.01 | 30.7 | 30.7 | 30.7 | 30.7 | 30.7 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 1.5 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | 1 | |||||||||
| Net Debt | 10 | |||||||||
| Equity Value | -8 | |||||||||
| Diluted Shares Outstanding, MM | 25 | |||||||||
| Equity Value Per Share | -0.34 |
What You Will Get
- Real NMRD Financial Data: Pre-filled with Nemaura Medical Inc.’s historical and projected data for precise analysis.
- Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
- Automatic Calculations: See Nemaura Medical Inc.’s intrinsic value update instantly based on your changes.
- Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
- User-Friendly Design: Simple structure and clear instructions for all experience levels.
Key Features
- Comprehensive DCF Calculator: Offers detailed unlevered and levered DCF valuation models tailored for Nemaura Medical Inc. (NMRD).
- WACC Calculator: Comes with a pre-built Weighted Average Cost of Capital sheet that allows for customizable inputs specific to NMRD.
- Adjustable Forecast Assumptions: Easily modify growth rates, capital expenditures, and discount rates to fit Nemaura Medical's projections.
- Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios specifically for Nemaura Medical Inc. (NMRD).
- Interactive Dashboard and Charts: Visual representations summarize essential valuation metrics for straightforward analysis of Nemaura Medical Inc. (NMRD).
How It Works
- Download the Template: Gain immediate access to the Excel-based NMRD DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and additional parameters.
- Instant Calculations: The model automatically recalculates Nemaura Medical's intrinsic value.
- Test Scenarios: Experiment with various assumptions to assess potential changes in valuation.
- Analyze and Decide: Utilize the outcomes to inform your investment or financial analysis.
Why Choose This Calculator for Nemaura Medical Inc. (NMRD)?
- Designed for Experts: A sophisticated tool utilized by healthcare analysts, investors, and financial consultants.
- Comprehensive Data: Nemaura Medical's historical and future financials are preloaded for precise analysis.
- Flexible Scenario Analysis: Effortlessly test various forecasts and assumptions to gauge potential outcomes.
- Insightful Results: Automatically computes intrinsic value, NPV, and essential financial metrics.
- User-Friendly Interface: Step-by-step guidance ensures a smooth experience throughout the process.
Who Should Use This Product?
- Investors: Assess Nemaura Medical Inc.’s (NMRD) valuation before making investment decisions.
- CFOs and Financial Analysts: Optimize valuation methodologies and evaluate financial forecasts.
- Startup Founders: Understand the valuation strategies of public companies like Nemaura Medical Inc. (NMRD).
- Consultants: Provide comprehensive valuation analyses and reports for clients.
- Students and Educators: Utilize current data to learn and teach valuation principles effectively.
What the Template Contains
- Historical Data: Includes Nemaura Medical Inc.’s (NMRD) past financials and baseline forecasts.
- DCF and Levered DCF Models: Detailed templates to calculate Nemaura Medical Inc.’s (NMRD) intrinsic value.
- WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
- Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
- Quarterly and Annual Statements: A complete breakdown of Nemaura Medical Inc.’s (NMRD) financials.
- Interactive Dashboard: Visualize valuation results and projections dynamically.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.